Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Sally Church

Sally Church

Interested in Pharma, Biotech, Science and cancer... Find me at also love food, wine, the NFL and cricket. Hi!
I+just+entered+to+win+a+personal+assistant+for+a+whole+year+%28worth+%2410%2C400%21%29+Enter+here%3A -
ASH 2011 Update #2 – Non Hodgkins Lymphoma -
ASH 2011 Update 1: Bruton’s Kinase Inhibitors (BTK) -
What’s hot at SABCS – Update 2 – advanced breast cancer -
Follow the American Society of Hematology ASH conversations! -
What’s hot at the American Society of Hematology 2011? -
Video preview of San Antonio Breast Cancer Symposium 2011 -
Follow the conversation from 2011 San Antonio Breast Cancer Symposium -
EGFR activates mTORC2 in glioblastoma – a potential role for new therapies -
Exciting new approach to targeted therapy in prostate cancer -
Update from AACR Molecular Targets 2011 #2 – Angiogenesis -
Update from AACR Molecular Targets 2011 #1 – Breast Cancer -
Epigenetics – an emerging new potential treatment for lung cancer? -
Update on pancreatic Neuroendocrine Tumours (NET) -
Redefining subsets of triple negative breast cancer -
How a metabolic protein PKM2 may have a key role in tumorigenesis -
Excellent news in Advanced Prostate Cancer – Medivation’s MDV3100 meets primary endpoint -
Understanding cancer metastasis – possible new therapeutic targets -
A year in the life of Pharma Strategy Blog -
Update on EGFR resistance in lung cancer: new directions -
Update on cabozantinib in medullary thyroid cancer -
Useful resource on new therapies for lung cancer -
The elusive mystery of KRAS and EGFR inhibitors in colorectal cancer -
Update on ADCs and immunotoxins in hematologic malignancies -
Other ways to read this feed:Feed readerFacebook